Page last updated: 2024-08-22

molybdenum and Head and Neck Neoplasms

molybdenum has been researched along with Head and Neck Neoplasms in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (55.56)29.6817
2010's3 (33.33)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Li, H; Li, J; Liu, M; Liu, T; Tu, Z; Wen, W; Xie, X; Zhang, S; Zhu, Y1
Akiyama, K; Hasegawa, K; Ibaragi, S; Kishimoto, K; Kunisada, Y; Monsur Hassan, NM; Okui, T; Ryumon, S; Sasaki, A; Shimo, T; Thu Ha, NT1
Hassan, NMM; Ibaragi, S; Morisawa, A; Nguyen, TTH; Okui, T; Okusha, Y; Ono, M; Sasaki, A; Shimo, T1
Islam, M; Kumar, P; Merajver, SD; Pan, Q; Patel, SN; Teknos, TN; Yadav, A1
Abarbanell, AM; Arenberg, DA; Carron, M; Carskadon, SL; Islam, M; Marcus, B; Merajver, SD; Nor, JE; Pan, Q; Paul, S; Teknos, TN; Vandenberg, CD1
Bolton, B; Brewer, G; Kariapper, MS; Khan, MK; Kwitny, A; Mamou, F; May, KS; Merajver, SD; Miller, M; Nair, BM; Normolle, D; Schipper, MJ; Teknos, TN; Warnat, A1
Hassouneh, B; Islam, M; Merajver, SD; Nagel, T; Pan, Q; Teknos, TN1
Khan, GN; Merajver, SD1
Barrios, M; Brewer, GJ; Cox, C; Dick, RD; Merajver, SD; Teknos, TN1

Reviews

1 review(s) available for molybdenum and Head and Neck Neoplasms

ArticleYear
Modulation of angiogenesis for cancer prevention: strategies based on antioxidants and copper deficiency.
    Current pharmaceutical design, 2007, Volume: 13, Issue:35

    Topics: Angiogenesis Inhibitors; Animals; Anticarcinogenic Agents; Antioxidants; Breast Neoplasms; Carotenoids; Cell Transformation, Neoplastic; Chelating Agents; Copper; Dietary Supplements; Female; Flavonoids; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Molybdenum; Neoplasms; Neovascularization, Pathologic; NF-kappa B; Phenols; Polyphenols; Prostatic Neoplasms; Reactive Oxygen Species

2007

Other Studies

8 other study(ies) available for molybdenum and Head and Neck Neoplasms

ArticleYear
Construction of CpG Delivery Nanoplatforms by Functionalized MoS
    Small (Weinheim an der Bergstrasse, Germany), 2023, Volume: 19, Issue:41

    Topics: Cytokines; Head and Neck Neoplasms; Humans; Immunotherapy; Molybdenum; Squamous Cell Carcinoma of Head and Neck; Tumor Microenvironment

2023
Ammonium tetrathiomolybdate enhances the antitumor effect of cisplatin via the suppression of ATPase copper transporting beta in head and neck squamous cell carcinoma.
    Oncology reports, 2019, Volume: 42, Issue:6

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Cisplatin; Copper-Transporting ATPases; Drug Resistance, Neoplasm; Drug Synergism; Head and Neck Neoplasms; Humans; Male; Mice; Molybdenum; Squamous Cell Carcinoma of Head and Neck; Tissue Array Analysis; Xenograft Model Antitumor Assays

2019
Ammonium tetrathiomolybdate enhances the antitumor effects of cetuximab via the suppression of osteoclastogenesis in head and neck squamous carcinoma.
    International journal of oncology, 2018, Volume: 52, Issue:3

    Topics: Animals; Antineoplastic Agents, Immunological; Bone Neoplasms; Bone Resorption; Carcinoma, Squamous Cell; Cetuximab; Chelating Agents; Copper; Drug Synergism; Female; Head and Neck Neoplasms; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Molybdenum; Neoplasm Invasiveness; Osteoclasts; Protein-Lysine 6-Oxidase; RANK Ligand; Squamous Cell Carcinoma of Head and Neck; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2018
Tetrathiomolybdate inhibits head and neck cancer metastasis by decreasing tumor cell motility, invasiveness and by promoting tumor cell anoikis.
    Molecular cancer, 2010, Aug-03, Volume: 9

    Topics: Angiogenesis Inhibitors; Anoikis; Carcinoma, Squamous Cell; Cells, Cultured; Head and Neck Neoplasms; Humans; Molybdenum; Neoplasm Invasiveness; Neoplasm Metastasis

2010
The effect of tetrathiomolybdate on cytokine expression, angiogenesis, and tumor growth in squamous cell carcinoma of the head and neck.
    Archives of otolaryngology--head & neck surgery, 2005, Volume: 131, Issue:3

    Topics: Angiogenesis Inhibitors; Animals; Biomarkers, Tumor; Biopsy, Needle; Carcinoma, Squamous Cell; Cell Movement; Cytokines; Disease Models, Animal; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Head and Neck Neoplasms; Humans; Immunohistochemistry; In Vitro Techniques; Mice; Mice, SCID; Molybdenum; Neovascularization, Pathologic; Probability; Rats; Rats, Sprague-Dawley; Risk Assessment; Sensitivity and Specificity; Species Specificity; Tumor Burden; Tumor Cells, Cultured

2005
Combination tetrathiomolybdate and radiation therapy in a mouse model of head and neck squamous cell carcinoma.
    Archives of otolaryngology--head & neck surgery, 2006, Volume: 132, Issue:3

    Topics: Angiogenesis Inhibitors; Animals; Carcinoma, Squamous Cell; Ceruloplasmin; Chelating Agents; Combined Modality Therapy; Head and Neck Neoplasms; Mice; Mice, Inbred C3H; Molybdenum; Random Allocation

2006
Tetrathiomolybdate promotes tumor necrosis and prevents distant metastases by suppressing angiogenesis in head and neck cancer.
    Molecular cancer therapeutics, 2007, Volume: 6, Issue:3

    Topics: Adenosine Triphosphatases; Angiogenesis Inhibitors; Animals; Carcinoma, Squamous Cell; Cell Movement; Ceruloplasmin; Disease Models, Animal; Head and Neck Neoplasms; Humans; Lung Neoplasms; Mice; Mice, Nude; Molybdenum; Necrosis; Neovascularization, Pathologic; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A

2007
The role of copper suppression as an antiangiogenic strategy in head and neck squamous cell carcinoma.
    The Laryngoscope, 2001, Volume: 111, Issue:4 Pt 1

    Topics: Angiogenesis Inhibitors; Animals; Awards and Prizes; Carcinoma, Squamous Cell; Ceruloplasmin; Chelating Agents; Copper; Head and Neck Neoplasms; Male; Mice; Mice, Inbred C3H; Molybdenum; Neoplasm Transplantation

2001